diabetestalk.net

This Extreme Diet Reversed Type 2 Diabetes In Up To 86% Of Patients

This Extreme Diet Reversed Type 2 Diabetes in Up to 86% of Patients

This Extreme Diet Reversed Type 2 Diabetes in Up to 86% of Patients

Type 2 diabetes isn't necessarily for life, with a new clinical trial providing some of the clearest evidence yet that the condition can be reversed, even in patients who have carried the disease for several years.
A clinical trial involving almost 300 people in the UK found an intensive weight management program put type 2 diabetes into remission for 86 percent of patients who lost 15 kilograms (33 lbs) or more.
"These findings are very exciting," says diabetes researcher Roy Taylor from Newcastle University.
"They could revolutionise the way type 2 diabetes is treated."
Taylor and fellow researchers studied 298 adults aged 20-65 years who had been diagnosed with type 2 diabetes within the previous six years to take part in the Diabetes Remission Clinical Trial (DiRECT).
Participants were randomly assigned to either an intensive weight management program or to regular diabetic care administered by their GP, acting as a control group.
For the 149 individuals placed in the weight management program, participants had to restrict themselves to a low calorie formula diet consisting of things like health shakes and soups, limiting them to consuming 825-853 calories per day for a period of three to five months.
After this, food was reintroduced to their diet slowly over two to eight weeks, and participants were given support to maintain their weight loss, including cognitive behavioural therapy and help with how to increase their level of physical activity.
Not an easy lifestyle change to adapt to, perhaps; but where there's a will, there's a way.
"We've found that people were re Continue reading

Rate this article
Total 1 ratings
Type 2 Diabetes and Peripheral Neuropathy: To Walk or Not to Walk?

Type 2 Diabetes and Peripheral Neuropathy: To Walk or Not to Walk?

It is now well known that engaging in light to moderate physical activity on a regular basis is of significant value for most people that have either Type 1 or Type 2 diabetes. In fact the American Diabetes Association recommends that people with diabetes should get a minimum of 150 minutes of light to moderate exercise per week including aerobic and resistance training.
What the ADA says...
It has also been recommended that people with peripheral diabetic neuropathy that have reduced or absent feeling in their feet should not engage in any form of weight bearing exercise activity. The American Diabetes Association recommends that people with diabetes-related peripheral neuropathy should limit the amount of weight-bearing physical activity they perform due to their increased risk of foot ulcers and amputation (1, 2). This is based on the fact that with peripheral neuropathy there is either a decreased ability or total inability in the feet to feel pain or discomfort.
As an example, standing barefoot on hot asphalt maybe in a parking lot in the middle of the summer would be very uncomfortable for someone with normal sensation in their feet, however go unnoticed for someone with peripheral neuropathy. Similarly, the person with peripheral neuropathy may develop a painful nickel-sized blister after walking too far or when wearing new shoes and not even feel it. Without daily inspection of the ankles and feet (which a lot of people do not do) this blister could go unnoticed for days resulting in a potentially infected, slow to heal, or non-healing wound. In the worst case this Continue reading

World Diabetes Day: Two types, one global problem

World Diabetes Day: Two types, one global problem

Today is World Diabetes Day and, for 2017, the International Diabetes Federation has declared the theme to be: Women and diabetes – our right to a healthy future. Diabetes is a global epidemic that shows no signs of abating and, according to the IDF, more than 199 million women are living with the disease; that figure is expected to climb to 313 million by the year 2040. A decade before that, the World Health Organisation believes that diabetes will be the seventh leading cause of death – yet the vast majority of cases are entirely avoidable.
Intrinsically linked with obesity, type 2 diabetes is by far the most common form, with just as many men affected as women. So what is it and what can be done to prevent it? Diabetes is when the pancreas produces insufficient levels of insulin (the hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it does produce. This, in turn, usually leads to a condition called hyperglycaemia, commonly known as raised blood sugar that, if left untreated, causes serious damage to the central nervous system and blood vessels. As a result, sufferers can go blind, need to have limbs amputated or end up having fatal heart attacks.
WHO records show that 35.4 million people suffer from diabetes in the Middle East and Africa alone, with the majority of sufferers unaware that the condition can gradually rob them of their sight, due to diabetic retinopathy – a condition where high blood sugar levels cause damage to the retina. So along with balancing their insulin levels, diabetics would do well to have Continue reading

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study

OBJECTIVE We assessed the prevalence of and risk factors for diabetic peripheral neuropathy (DPN) in youth with type 1 diabetes (T1D) and type 2 diabetes (T2D) enrolled in the SEARCH for Diabetes in Youth (SEARCH) study.
RESEARCH DESIGN AND METHODS The Michigan Neuropathy Screening Instrument (MNSI) was used to assess DPN in 1,734 youth with T1D (mean ± SD age 18 ± 4 years, T1D duration 7.2 ± 1.2 years, and HbA1c 9.1 ± 1.9%) and 258 youth with T2D (age 22 ± 3.5 years, T2D duration 7.9 ± 2 years, and HbA1c 9.4 ± 2.3%) who were enrolled in the SEARCH study and had ≥5 years of diabetes duration. DPN was defined as an MNSI exam score of >2. Glycemic control over time was estimated as area under the curve for HbA1c.
RESULTS The prevalence of DPN was 7% in youth with T1D and 22% in youth with T2D. Risk factors for DPN in youth with T1D were older age, longer diabetes duration, smoking, increased diastolic blood pressure, obesity, increased LDL cholesterol and triglycerides, and lower HDL cholesterol (HDL-c). In youth with T2D, risk factors were older age, male sex, longer diabetes duration, smoking, and lower HDL-c. Glycemic control over time was worse among those with DPN compared with those without for youth with T1D (odds ratio 1.53 [95% CI 1.24; 1.88]) but not for youth with T2D (1.05 [0.7; 1.56]).
CONCLUSIONS The high rates of DPN among youth with diabetes are a cause of concern and suggest a need for early screening and better risk factor management. Interventions in youth that address poor glycemic control and dyslipidemia may prevent or delay debilitating neuropa Continue reading

Metformin Side Effects And How To Deal With Them

Metformin Side Effects And How To Deal With Them

Metformin side effects include diabetic neuropathy, brain fog, and digestive issues. You can address them through diet, Vitamin B12, CoQ10, and exercise. Let us understand the drug Metformin in detail and study different forms of metformin, its uses and common metformin side effects along with how to deal with them.
Metformin: What Is It Used For?
Metformin is an old warhorse in the pharma battle against diabetes. It has been the mainstay in the treatment of Type 2 Diabetes for more than fifty years, often matching or outperforming newer drugs.
In fact, many new combination drugs are often created with metformin as one of the main ingredients. Thanks to its long run in the pharmaceutical world, the side effects of Metformin are also well known.
The Metformin-PCOS connection has been studied extensively since a majority of health complications associated with PCOS (polycystic ovarian syndrome) are due to hyperinsulinemia (high amounts of insulin in the blood stream). Metformin is known to reduce circulating insulin levels. The use of this drug in women with PCOS has shown highly encouraging results.
RELATED: 10 Easy Breakfast Ideas For Diabetics
Most Prescribed Names in Metformin Category Include:
Fortamet:
It is an extended-release formulation that contains metformin hydrochloride. The tablets are designed for once-a-day administration. They deliver either 500 mg or 1000 mg of metformin. The tablet is made using a patented technology called SCOTTM that delivers the active compound slowly and at a constant rate.
Glucophage:
Glucophage tablets contain metformin hydrochoride. Continue reading

No more pages to load

Popular Articles

Related Articles